|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBSCO_on1082975873 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
190119s2018 xx o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d N$T
|d OCLCF
|d OCLCQ
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 019 |
|
|
|a 1082877541
|
| 020 |
|
|
|a 168108760X
|
| 020 |
|
|
|a 9781681087603
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)1082975873
|z (OCoLC)1082877541
|
| 050 |
|
4 |
|a RC683.5.R33
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.1207575
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Matsuo, Shinro.
|
| 245 |
1 |
0 |
|a Clinical Nuclear Cardiology
|
| 260 |
|
|
|a Sharjah :
|b Bentham Science Publishers,
|c 2018.
|
| 300 |
|
|
|a 1 online resource (277 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Frontiers in Myocardia Ser. ;
|v v. 2
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover; Title; Biblography; End User License Agreement; Contents; Foreword; Preface; List of Contributors; Diagnosis of Coronary Artery Disease with Myocardial Perfusion Imaging; Shinro Matsuo*; INTRODUCTION; Diagnosing Ischemia or Infarction; Cardiac Function; SPECT/CT; Risk Stratification; Normal Myocardial Perfusion Imaging; Evaluation of Ischemia; IQ-SPECT (SMARTZOOM Collimator); Quantitative Myocardial Flow Measurement with CZT Camera; Mitochondrial Function Imaging; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES
|
| 505 |
8 |
|
|a Gated Myocardial Perfusion Imaging and Risk-Stratification in Coronary Artery Disease and Heart FailureTomoaki Nakata1,*, Kenji Sato1 and Kei Nakata1,2; GATED MYOCARDIAL PERFUSION IMAGING TECHNOLOGY; Clinical Implications of Gated MPI; Risk-Stratification in Coronary Artery Disease; Risk-Stratification in Heart Failure; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Myocardial Viability Assessment in Predicting Prognosis and Providing Optimal Management for Ischemic Left Ventricular Dysfunction; Tokuo Kasai*; INTRODUCTION
|
| 505 |
8 |
|
|a Impact of Myocardial Viability on Patient ManagementPathophysiology of Reversible Ischemic Dysfunction; Structural Alteration of Hibernating Myocardium; Metabolic Alteration in Reversible Ischemic Dysfunction; Role of Imaging in Assessing Reversible Ischemic Dysfunction; Amount of Residual Ischemic Myocardium; LV Remodeling; Viability and Cardiac Resynchronization Therapy; CONCLUSION; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Cardiac Hybrid or Fusion Imaging and Future Prospective; Shinro Matsuo*; INTRODUCTION; Anatomic and Physiological Stenosis
|
| 505 |
8 |
|
|a Quantitative Evaluation of Myocardial IschemiaFusion Imaging of CT Angiography and SPECT; The Benefits of Fusion Imaging; The Coronary Artery Calcification Evaluation by SPECT / CT; Fusion Diagnosis of Functional Information and Blood Flow; CONCLUSION; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Positron Emission Tomography Myocardial Perfusion Imaging; Keiichiro Yoshinagaa, * and Osamu Manabeb; TRACERS FOR PET MYOCARDIAL PERFUSION IMAGING; Rubidium-82; 15O-labeled Water; 18Fluorine-labeled Myocardial Perfusion Agents; C-11-labeled PET Agents; 11C-acetate
|
| 505 |
8 |
|
|a 11C-HEDCLINICAL INDICATION AND IMAGING PROTOCOLS; Clinical Indication; Imaging Protocol; Patient Preparation; Stress Protocol; Pharmacological Vasodilator Stress; Dobutamine Stress; Image Acquisition and Processing; 82Rubidium; 15O-labeled Water; Assessment of Absolute Myocardial Blood Flow; CLINICAL APPLICATIONS; Diagnosis in Coronary Artery Disease; Visual Assessment; MBF Assessment; Prognosis in Coronary Artery Disease; Visual Analysis; Quantitative Analysis; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Myocardial Perfusion Imaging and other Modalities
|
| 500 |
|
|
|a Yasuyo Taniguchi*
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Heart
|x Radionuclide imaging.
|
| 650 |
|
6 |
|a Cœur
|x Scintigraphie.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Heart
|x Radionuclide imaging.
|2 fast
|0 (OCoLC)fst00953650
|
| 776 |
0 |
8 |
|i Print version:
|a Matsuo, Shinro.
|t Clinical Nuclear Cardiology: Practical Applications and Future Directions.
|d Sharjah : Bentham Science Publishers, ©2018
|
| 830 |
|
0 |
|a Frontiers in Myocardia Ser.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2000814
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5631989
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2000814
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 15980533
|
| 994 |
|
|
|a 92
|b IZTAP
|
